Ambu
116.3 DKK -0.3%5 investors are following this company
Ambu is a pharmaceutical company. The company develops and markets diagnostic equipment for actors in care and welfare. The largest activities are found in the development of solutions for anesthesia, patient monitoring, diagnosis, and equipment for first aid. Operations are held on a global level with the largest presence in Europe and North America. Ambu was founded in 1937 and is headquartered in Ballerup, Denmark.
Revenue
4.78B
EBIT %
6.16 %
P/E
181.72
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Copenhagen
AMBU B
Daily low / high price
115.95 / 117.4
DKK
Market cap
31.32B DKK
Turnover
6.05M DKK
Volume
52K
Latest videos
Financial calendar
Interim report
14.05.2024
Interim report
30.08.2024
Annual report
05.11.2024
General meeting
04.12.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
N.P. Louis Hansen Aps, Nivå | 14.3 % | 6.5 % |
Hannah Hesse, Frederiksberg | 3.0 % | 10.5 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
AMBU RAISES OUTLOOK FOR THE 2023/24 FINANCIAL YEAR
Ambu A/S: Reporting of transactions made by persons discharging managerial responsibilities
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools